Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...


Therapeutic Developments in Friedreich Ataxia

Friedreich ataxia is an inherited, severe, progressive neuro- and cardiodegenerative disorder for which there currently is no approved therapy. Friedreich ataxia is caused by the decreased expression and/or function of frataxin, a mitochondrial matrix protein that binds iron and is involved in the formation of iron-sulfur clusters. Decreased frataxin function leads to decreased iron-sulfur cluster formation, mitochondrial iron accumulation, cytosolic iron depletion, oxidative stress, and mitochondrial dysfunction.

Read More: Therapeutic Developments in Friedreich Ataxia

About the Author

Jen Farmer

Jen Farmer

Executive Director


Event D.jpg


Archived in
  Scientific News



Tagged in
FARA Scientific News

Site Map     Privacy Policy     Service Terms     Log-in     Contact     Charity Navigator